Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
DET is believed to be non-habit-forming, and the desire to use it may actually decrease with continued use, consistent with the typical profile of classic psychedelics.
No physical dependence or withdrawal syndrome has been documented. Rapid tolerance development naturally limits frequent use patterns.
The exact toxic dose is unknown as DET is a research chemical with limited history of human usage. It is presumed to have a similar toxicity profile to DMT due to structural similarities.
Like other classic psychedelics, DET can produce acute psychotic-like symptoms including delusions, paranoia, and perceptual disturbances during intoxication. Early research explored DET as a psychotomimetic model, though this framework has since been largely dismissed by researchers. Risk may be elevated in predisposed individuals.
No direct seizure risk documented for DET alone. As with other psychedelics, it may act as a seizure trigger in predisposed individuals, particularly when combined with substances that lower seizure threshold.
DET was first synthesized in 1956 by Hungarian chemist Stephen Szára, with his findings published the following year. More systematic studies were subsequently conducted by Szára and colleagues, as well as independently by Böszörményi and colleagues. Despite being a close structural analog of DMT,…
UN Convention on Psychotropic Substances 1971 (Schedule I)
Controlled under the Poisons Standard. Classified as a substance subject to abuse or misuse; manufacture, possession, sale, or use is prohibited except for approved medical or scientific research, analytical, teaching, or training purposes with Commonwealth and/or State or Territory Health Authority approval.
Listed in Anlage I of the Betäubungsmittelgesetz (Narcotics Act) since January 24, 1974. Manufacturing, possession, import, export, purchase, sale, procurement, or dispensing without a license is prohibited.
Controlled as a Class A substance, the most restrictive category under New Zealand drug legislation, carrying the most severe penalties.
Specifically named as a controlled substance under Verzeichnis D of Swiss narcotics legislation.
Controlled under the Controlled Substances Act as a Schedule I hallucinogen, indicating high abuse potential and no accepted medical use. Manufacturing, buying, possessing, or distributing without a DEA license is a federal offense.
Controlled under the Controlled Drugs and Substances Act. Canadian scheduling differs significantly from the United States system in terms of penalties and associated restrictions.
Listed in Tabella I of the Tabelle delle sostanze stupefacenti e psicotrope (Tables of Narcotic and Psychotropic Substances). Possession, purchase, and sale are illegal.
Classified under the Drug and Drug Trafficking Act No. 140 of 1992 as an undesirable dependence-producing substance, subjecting it to criminal penalties for unauthorized possession or distribution.
Controlled as a Class A, Schedule 1 substance under the Misuse of Drugs Act 1971. Purchasing or possessing without a Home Office license is illegal.
10 sources cited